Document is current
Any future updates will be listed below
-
Authors
Zwartkruis, M. M.
Elferink, M. G.
Gommers, D.
Signoria, I.
Blasco-Pérez, L.
Costa-Roger, M.
van der Sel, J.
Renkens, I. J.
Green, J. W.
Kortooms, J. V.
Vermeulen, C.
Straver, R.
van Deutekom, H. W. M.
Veldink, J. H.
Asselman, F.
Tizzano, E. F.
Wadman, R. I.
van der Pol, W. L.
van Haaften, G. W.
Groen, E. J. N.
- License Information
-
More Information
Article History
Received: 18 September 2024
Accepted: 7 March 2025
First Online: 21 March 2025
Declarations
:
: The study protocol (09307/NL29692.041.09) was approved by the Medical Ethical Committee of the University Medical Center Utrecht and registered at the Dutch registry for clinical studies and trials []. Written informed consent was obtained from all adult patients, and from patients and/or parents additionally in the case of children younger than 18 years old.
: Not applicable.
: JHV reports to have sponsored research agreements with Biogen and Astra Zeneca. The remaining authors declare that they do not have any competing interests.
